Danaher Corporation (DHR)

NYQ – Real Time Price. Currency in USD

166.26

-0.26 (-0.16%)

At close: May 12, 2026, 4:00 PM EDT

165.99

-0.26 (-0.16%)

Pre-market: May 13, 2026, 4:17 AM EDT

06.05.2026

Danaher to Present at Bank of America Securities Healthcare Conference

WASHINGTON, May 6, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 13, 2026 at 11:20 a.m.

05.05.2026

Danaher Announces Quarterly Dividend

WASHINGTON, May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 31, 2026 to holders of record on June 26, 2026. ABOUT DANAHER Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.

04.05.2026

Masimo Shareholders Approve Acquisition by Danaher

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced Agreement and Plan of Merger, dated February 16, 2026 (the “Merger Agreement”), by and among Masimo, Danaher Corporation (“Danaher”) (NYSE: DHR) and Mobius Merger Sub, Inc. (the “Merger Sub”) at Masimo's special meeting of stockholders held virtually on May 1, 2026 (.

28.04.2026

Xylem Q1 Earnings Beat Estimates, Revenues Increase Y/Y

XYL tops Q1 estimates as Measurement & Control demand lifts results, while raising 2026 revenue outlook.

23.04.2026

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher reached a $172.5 million settlement with shareholders who accused the diagnostics and life-sciences company of defrauding them by overstating ‌demand for its equipment as the worst of the COVID-19 pandemic passed.

22.04.2026

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

WASHINGTON, April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"): €500,000,000 principal amount of floating rate senior notes due 2028 at an offering price of 100.000% of the principal amount; €750,000,000 principal amount of 3.250% senior notes due 2030 at an offering price of 99.934% of the principal amount; €750,000,000 principal amount of 3.625% senior notes due 2034 at an offering price of 99.918% of the principal amount; and €1,000,000,000 principal amount of 4.000% senior notes due 2038 at an offering price of 99.953% of the principal amount (collectively, the "senior notes"). Danaher estimates that the net proceeds from the sale of the senior notes will be approximately €2.98 billion, after deducting the underwriting discounts and estimated offering expenses payable by Danaher.

22.04.2026

Danaher Q1 2026 Earnings Update

Danaher had another somewhat uneventful quarter. Margin in biotechnology segment improved YoY to reach 42.7% in 1Q'26. Life Sciences segment's core revenue grew at only 0.5% despite having an easy comp of -4% in 1Q'25.

Danaher Reports First Quarter 2026 Results

WASHINGTON, April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted.

Danaher Corporation (DHR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Danaher Corporation (DHR)

Danaher to Present at Bank of America Securities Healthcare Conference

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Xylem Q1 Earnings Beat Estimates, Revenues Increase Y/Y

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Q1 2026 Earnings Update

Videos

Press releases

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Reports First Quarter 2026 Results

Danaher to Present at Bank of America Securities Healthcare Conference

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Xylem Q1 Earnings Beat Estimates, Revenues Increase Y/Y

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Q1 2026 Earnings Update

Videos

Press releases

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Reports First Quarter 2026 Results

Search stocks

Danaher Corporation (DHR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Danaher Corporation (DHR)

Danaher to Present at Bank of America Securities Healthcare Conference

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Xylem Q1 Earnings Beat Estimates, Revenues Increase Y/Y

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Q1 2026 Earnings Update

Videos

Press releases

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Reports First Quarter 2026 Results

Danaher to Present at Bank of America Securities Healthcare Conference

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Xylem Q1 Earnings Beat Estimates, Revenues Increase Y/Y

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Q1 2026 Earnings Update

Videos

Press releases

Danaher Announces Quarterly Dividend

Masimo Shareholders Approve Acquisition by Danaher

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Reports First Quarter 2026 Results